12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movement in Monday's intraday session. Pasithea Therapeutics (KTTA) saw a 105.9% increase, while Cogent Biosciences (COGT) declined by 53.5%. Other notable gainers include Assure Hldgs (IONM), Marker Therapeutics (MRKR), MorphoSys (MOR), G1 Therapeutics (GTHX), and Cognition Therapeutics (CGTX). On the losing side, alongside COGT, were Altamira Therapeutics (CYTO), X4 Pharmaceuticals (XFOR), Jaguar Health (JAGX), Biomea Fusion (BMEA), and Vapotherm (VAPO).

December 11, 2023 | 5:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cogent Biosciences shares fell sharply by 53.5% to $4.01, with a market cap of $345.7 million.
The dramatic decline in stock price could reflect investor concerns or negative developments within the company, likely leading to bearish short-term prospects.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Cognition Therapeutics stock increased by 18.67% to $1.97, with a market cap of $60.9 million.
The stock's rise could be due to favorable investor perception or recent positive news, which might lead to continued short-term growth.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
G1 Therapeutics stock advanced by 20.06% to $3.77, with a market cap of $195.4 million.
The stock's gain suggests investor optimism, which may be based on recent company developments or broader sector movements, potentially leading to further short-term appreciation.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Assure Hldgs stock rose by 32.54% to $0.47, with a market cap of $3.1 million.
The significant rise in stock price may be driven by positive news or investor optimism, potentially leading to further short-term gains.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Pasithea Therapeutics stock surged by 105.9% to $0.62, with a market cap of $12.8 million.
The substantial increase in stock price suggests positive investor sentiment or reaction to company-specific news, which could lead to continued short-term momentum.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
MorphoSys stock climbed 26.09% to $8.89, with a market cap of $1.2 billion.
The increase in MorphoSys's stock price may be attributed to positive market sentiment or company-specific news, which could have a favorable short-term impact.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Marker Therapeutics stock increased by 30.51% to $4.19, with a market cap of $37.2 million.
The stock's upward trend indicates investor confidence, which may continue to influence the stock's performance in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 90